Kinematic Evaluation for Impairment of Skilled Hand Function in Chemotherapy-induced Peripheral Neuropathy
Overview
Affiliations
Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) usually affects both sensory and motor function of hands and feet, resulting in impaired skilled hand function (e.g., typing a keyboard). However, quantitative and objective evaluations for this condition have not been established.
Purpose Of The Study: We evaluated skilled hand function using a kinematic analysis and investigated relationships among hand kinematic function and the clinical sensory and motor features of CIPN.
Study Designs: Clinical measurement.
Methods: Twelve CIPN patients and 12 age-matched control participants were enrolled. We recorded their reach and grasp movements using a three-dimensional measurement system, and calculated the normalized jerk of these movements as quantitative indexes of skilled hand function. Additionally, we used the number of sequential hand grip-release cycles in 10 seconds as an evaluation of clinical motor function.
Results: Our kinematic analyses revealed significant difference in normalized jerk of grasp movement (CIPN: 3.7 ± 0.2, control: 3.4 ± 0.1; P = .005), but this was not the case for reach movement (CIPN: 2.5 ± 0.1, control: 2.5 ± 0.2; P = .43), indicating that the distal part of the forearm is particularly affected in CIPN. Such disturbed grasp movement was directly correlated with poor scores on the hand grip-release test and the sensory tests.
Discussion: We revealed deficit impaired hand function objectively and quantitatively in CIPN patients using a kinematic analysis. Further, the hand grip test could represent such kinematic abnormality and could be useful for evaluating skilled hand function of CIPN patients.
Conclusions: Our kinematic and clinical measurements objectively and quantitatively evaluate skilled hand function in individuals with CIPN in clinical settings.
Level Of Evidence: Cross-sectional observational study.
Liu Y, Esser P, Weedon B, Springett D, Joshi S, Tsou M Ital J Pediatr. 2024; 50(1):200.
PMID: 39343969 PMC: 11440888. DOI: 10.1186/s13052-024-01765-z.
Manfuku M, Inoue J, Yamanaka N, Kanamori H, Sumiyoshi K, Osumi M Support Care Cancer. 2024; 32(5):304.
PMID: 38652168 DOI: 10.1007/s00520-024-08504-4.
Canille R, Pinto M, Galisteu K, Czorny R, Bertolazzi L, Faria T Rev Bras Enferm. 2023; 76(1):e20220161.
PMID: 36722645 PMC: 9885362. DOI: 10.1590/0034-7167-2022-0161.
Chen C, Kim J, Garg N, Guntupalli H, Jagsi R, Griggs J JMIR Mhealth Uhealth. 2022; 9(7):e27502.
PMID: 36260403 PMC: 8406129. DOI: 10.2196/27502.
Cancer survivors post-chemotherapy exhibit unique proprioceptive deficits in proximal limbs.
Wang A, Housley S, Flores A, Cope T, Perreault E J Neuroeng Rehabil. 2022; 19(1):32.
PMID: 35321749 PMC: 8944065. DOI: 10.1186/s12984-022-01010-w.